Yoshihiro Wakabayashi

Tokyo Medical University Hospital — Japan

Medicine · Health Sciences

32h-index3.9kcitations158works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(39), Hypothalamic control of reproductive hormones(30), Retinal and Optic Conditions(24), Ovarian function and disorders(18), Olfactory and Sensory Function Studies(15)

Publications158 total

Surgical Outcomes of Binocular Metamorphopsia in Unilateral Epiretinal Membrane: Risk of New-Onset Binocular Metamorphopsia After Vitrectomy
Translational Vision Science & Technology·2025Open Access
An Approach to Predict Intraocular Diseases by Machine Learning Based on Vitreous Humor Immune Mediator Profile
Investigative Ophthalmology & Visual Science·2025· 3 citedOpen Access
Peripheral administration of a κ-opioid receptor agonist nalfurafine inactivates gonadotropin-releasing hormone pulse generator activity in goats
Neuroscience Letters·2024· 2 citedOpen Access
Characteristics of Patients Who Drop Out of Anti‐Vascular Endothelial Growth Factor Therapy for Macular Edema Associated with Branch Retinal Vein Occlusion
Journal of Ophthalmology·2024Open Access
Immune Mediators Profiles in the Aqueous Humor of Patients with Simple Diabetic Retinopathy
Journal of Clinical Medicine·2023· 10 citedOpen Access
Healing rate of macular edema secondary to branch retinal vein occlusion in two years after initiation of intravitreal ranibizumab later combined with other treatment as needed and characteristics of refractory cases
PLoS ONE·2023· 3 citedOpen Access
Continuous acceleration of neural activity of the GnRH pulse generator during chronic peripheral infusion of neurokinin 3 receptor agonist in goats
Journal of Reproduction and Development·2023· 3 citedOpen Access
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup
Advances in Therapy·2022· 12 citedOpen Access
Ectopic inner foveal layer as a factor associated with metamorphopsia after vitrectomy for epiretinal membrane
Acta Ophthalmologica·2022· 11 cited
Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
Journal of Ophthalmology·2021· 3 citedOpen Access
Neovascular age‐related macular degeneration inactivated during systemic administration of an immune checkpoint inhibitor pembrolizumab for lung cancer
Acta Ophthalmologica·2021· 2 cited
Long-Term Outcome of Anti-Vascular Endothelial Growth Factor Therapy Following Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
2021Open Access
Case of peripheral fibrovascular proliferative retinopathy associated with morning glory disc anomaly
American Journal of Ophthalmology Case Reports·2021Open Access
Machine Learning Approach for Intraocular Disease Prediction Based on Aqueous Humor Immune Mediator Profiles
Ophthalmology·2021· 54 citedOpen Access
Silkworm recombinant bovine zona pellucida protein 4 (bZP4) as a potential female immunocontraceptive antigen; impaired sperm-oocyte interaction and ovarian dysfunction
Journal of Reproduction and Development·2021· 3 citedOpen Access
Local administration of Neurokinin B in the arcuate nucleus accelerates the neural activity of the GnRH pulse generator in goats
Journal of Reproduction and Development·2021· 11 citedOpen Access
Vitreous metabolomics profiling of proliferative diabetic retinopathy
Diabetologia·2020· 81 citedOpen Access
Neurokinin 3 receptor–selective agonist, senktide, decreases core temperature in Japanese Black cattle
Domestic Animal Endocrinology·2020· 1 cited
Correlation of the clinical severity of atopic dermatitis with ocular comorbidities
Journal of Cutaneous Immunology and Allergy·2020· 1 citedOpen Access
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR
Advances in Therapy·2020· 245 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Hiroaki Okamura(17), Yoshihiko Usui(13), Satoshi Ohkura(12), Hiroshi Gotô(11), Yuji Mori(9), Yoko Okunuki(8), Takeshi Kezuka(7), Hiroko Tsukamura(6), Daisuke Muramatsu(6), Yukari Takeuchi(6), Kei‐ichiro Maeda(5), Takashi Yamamura(5), Takuya Iwasaki(5), Masumi Ichikawa(5), Ken T. Murata(4), Yoshihisa Uenoyama(4), Y. Mori(4), Shunichiro Ueda(4), Kazuhiko Umazume(4), Kohei Sakamoto(4)